Sonata Capital Group Decreased Position in Amazon.Com (AMZN) by $817,224; As Grifols Sa (GRFS) Share Value Declined, Lenox Wealth Management Lifted Stake by $4.44 Million

Grifols, S.A. (NASDAQ:GRFS) Logo

Sonata Capital Group Inc decreased its stake in Amazon.Com Inc (AMZN) by 15.17% based on its latest 2018Q3 regulatory filing with the SEC. Sonata Capital Group Inc sold 408 shares as the company’s stock declined 15.37% with the market. The institutional investor held 2,281 shares of the consumer services company at the end of 2018Q3, valued at $4.57M, down from 2,689 at the end of the previous reported quarter. Sonata Capital Group Inc who had been investing in Amazon.Com Inc for a number of months, seems to be less bullish one the $805.57 billion market cap company. The stock increased 0.12% or $1.99 during the last trading session, reaching $1640. About 2,223 shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 41.49% since February 14, 2018 and is uptrending. It has outperformed by 41.49% the S&P500. Some Historical AMZN News: 23/04/2018 – InsideEVs: Shouldn’t Amazon Be Placing A Tesla Semi Order?; 25/04/2018 – Denver Biz Journal: EXCLUSIVE: Amazon’s HQ2 scouts asked Denver leaders about tackling growth issues; 19/03/2018 – RichRelevance Digital Grocery Survey Finds Amazon Takes Early Lead – But 60% of First-Time Shoppers Willing to Explore a New; 06/04/2018 – Postmates and DoorDash have discussed a merger to fend off Uber, GrubHub and Amazon; 02/04/2018 – Bank of America Merrill Lynch tells its clients that mutual funds have significantly larger stakes in Amazon and Netflix compared to the market indexes; 24/04/2018 – Amazon CEO says right for big companies to be scrutinized; 03/04/2018 – MEDIA-Amazon Music subscriptions have grown more than 100 pct in past six months – The Verge; 07/03/2018 – Amazon says it’s aware that some Echo devices are creepily laughing at people, and it’s working on a fix; 18/05/2018 – Odds & Ends: Amazon’s Tax Compromise, The Final 20 for HQ2, An Unconventional Tech CEO, Women in Tech — Barron’s Blog; 08/03/2018 – Berkshire Hathaway’s Todd Combs is leading the CEO search for the company’s health joint venture with Amazon and JPMorgan

Lenox Wealth Management Inc increased its stake in Grifols Sa (GRFS) by 618.4% based on its latest 2018Q3 regulatory filing with the SEC. Lenox Wealth Management Inc bought 211,609 shares as the company’s stock declined 5.76% with the market. The institutional investor held 245,828 shares of the health care company at the end of 2018Q3, valued at $5.25 million, up from 34,219 at the end of the previous reported quarter. Lenox Wealth Management Inc who had been investing in Grifols Sa for a number of months, seems to be bullish on the $16.12 billion market cap company. The stock increased 1.23% or $0.23 during the last trading session, reaching $19. About 1.32 million shares traded or 59.56% up from the average. Grifols, S.A. (NASDAQ:GRFS) has declined 13.56% since February 14, 2018 and is downtrending. It has underperformed by 13.56% the S&P500. Some Historical GRFS News: 05/03/2018 Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S; 05/03/2018 – GRIFOLS – ANNOUNCES NEW AGREEMENT WITH HENRY SCHEIN TO DISTRIBUTE NORMAL SALINE SOLUTION IN THE U.S; 22/03/2018 – GRIFOLS GRLS.MC SAYS CONCLUDES EXPERIMENTAL PHASE OF AMBAR, A CLINICAL TRIAL ON ALZHEIMER’S DISEASE; 05/03/2018 – GRIFOLS,HENRY SCHEIN IN PACT FOR NORMAL SALINE SOLUTION IN US; 14/05/2018 – Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents; 05/04/2018 – Aradigm Announces the EMA Has Completed Its Validation of the MAA Submission; 24/04/2018 – Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent lnvolved in Delaware Infringement Case; 20/03/2018 – Grifols to Buy Germany’s Haema for EUR220 Million; 25/05/2018 – GRIFOLS GRLS.MC – TO PAY GROSS DIVIDEND OF 0.204 EUR/SHR AGAINST FY 2017; 05/03/2018 – GRIFOLS – IN 2018, GRIFOLS WILL CONTINUE EXPANSION OF ITS CAPACITY IN ITS INDUSTRIAL COMPLEX IN BARCELONA

Among 5 analysts covering Grifols SA (NASDAQ:GRFS), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Grifols SA had 11 analyst reports since August 17, 2015 according to SRatingsIntel. Morgan Stanley downgraded Grifols, S.A. (NASDAQ:GRFS) on Monday, January 4 to “Underweight” rating. Morgan Stanley maintained it with “Underweight” rating and $19 target in Wednesday, January 2 report. On Tuesday, January 3 the stock rating was upgraded by JP Morgan to “Overweight”. The stock of Grifols, S.A. (NASDAQ:GRFS) earned “Hold” rating by HSBC on Wednesday, December 2. The stock of Grifols, S.A. (NASDAQ:GRFS) earned “Hold” rating by Berenberg on Friday, February 8. The rating was upgraded by Berenberg on Tuesday, February 9 to “Buy”. Morgan Stanley maintained Grifols, S.A. (NASDAQ:GRFS) on Monday, October 1 with “Underweight” rating. The firm has “Buy” rating by Nomura given on Thursday, March 17. Berenberg downgraded the stock to “Hold” rating in Friday, November 20 report.

Lenox Wealth Management Inc, which manages about $693.17M and $336.29 million US Long portfolio, decreased its stake in Ishares 10 (TLH) by 7,129 shares to 9,739 shares, valued at $1.25 million in 2018Q3, according to the filing. It also reduced its holding in Amadeus It Group Sa (AMADY) by 5,827 shares in the quarter, leaving it with 45,440 shares, and cut its stake in Berkshire Hathaway Inc B (BRKB).

More important recent Grifols, S.A. (NASDAQ:GRFS) news were published by: Benzinga.com which released: “33 Stocks Moving In Friday’s Pre-Market Session – Benzinga” on February 08, 2019, also Nasdaq.com published article titled: “European ADRs Move Lower in Thursday Trading – Nasdaq”, Streetinsider.com published: “Grifols (GRFS) Announces FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System – StreetInsider.com” on February 07, 2019. More interesting news about Grifols, S.A. (NASDAQ:GRFS) was released by: Seekingalpha.com and their article: “Rigel Pharma teams up with Grifols on Tavalisse; shares up 9% premarket – Seeking Alpha” with publication date: January 23, 2019.

Among 57 analysts covering Amazon.com (NASDAQ:AMZN), 54 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 334 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Bank of America with “Buy” on Friday, February 2. The firm has “Buy” rating by Canaccord Genuity given on Thursday, December 1. UBS maintained the stock with “Buy” rating in Friday, July 29 report. The company was maintained on Thursday, April 19 by Piper Jaffray. The rating was maintained by Robert W. Baird with “Buy” on Tuesday, August 15. The company was maintained on Friday, July 29 by Citigroup. J.P. Morgan maintained Amazon.com, Inc. (NASDAQ:AMZN) on Wednesday, May 31 with “Buy” rating. The firm earned “Buy” rating on Tuesday, August 29 by Robert W. Baird. The firm earned “Overweight” rating on Friday, October 26 by Barclays Capital. Raymond James upgraded the shares of AMZN in report on Thursday, August 27 to “Outperform” rating.

Since August 15, 2018, it had 0 insider buys, and 16 selling transactions for $75.62 million activity. Olsavsky Brian T sold $3.87M worth of Amazon.com, Inc. (NASDAQ:AMZN) on Wednesday, August 15. Another trade for 500 shares valued at $952,500 was sold by McGrath Judith A. On Thursday, November 15 the insider Blackburn Jeffrey M sold $3.22 million. Shares for $27.69 million were sold by BEZOS JEFFREY P on Monday, October 29. Reynolds Shelley sold $687,447 worth of Amazon.com, Inc. (NASDAQ:AMZN) on Thursday, November 15. STONESIFER PATRICIA Q sold 1,375 shares worth $2.31 million.

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart